Lebanon National Drugs Database

عربي

English

Quick links

links

Related sites

Arabic

الخط الساخن للخدمات الصحية للنازحين اللبنانيين 1787

الخط الساخن لوزارة الصحّة العامة 1214

Are you a new member? Sign up now

Track your Documents Are you a Physician?

Forgot your password? Click here

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J07CA09	HEXAXIM	BioTech	Diphteria Toxoid - ?20IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg		Injectable suspension	4,462,901 L.L
A10AD05	NOVOMIX 30	BioTech	Insulin aspart - 30%, Insulin aspart protamine - 70%	100IU/ml	Injectable suspension	4,264,012 L.L
J07CA11	DIPHTHERIA, TETANUS,PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE	B	Diphteria Toxoid1 - ?25Lf (?30IU)/0.5ml, Tetanus toxoid1 - ?2.5Lf (?40IU)/0.5ml, Bordetella pertussis (Whole cell) - ?16OU (?4.0IU)/0.5ml, HBs Antigen (r DNA)1 - ?10mcg/0.5ml, H. Influenza type b, purified capsular polysaccharide2 - 10mcg/0.5ml, 1 adsorbed on aluminium phosphate, Al+++ - ?1.25mg , 2 conjugated to tetanos toxoid carrier protein -		Injectable suspension	1,515,854 L.L
A10AD05	NOVOMIX 30	BioTech	Insulin aspart - 30%, Insulin aspart protamine - 70%	100IU/ml	Injectable suspension	4,264,012 L.L
A10AE01	HUMULIN N U-100	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable suspension	701,486 L.L
A10AE01	INSULATARD	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable suspension	752,552 L.L
A10AE01	INSULATARD	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable suspension	752,552 L.L
A10AE01	JUSLINE N	BioTech	Insulin human isophane - 100IU/ml	100IU/ml	Injectable suspension	401,809 L.L
L02AE03	ZOLADEX LA	B	Goserelin (acetate) - 10.8mg	10.8mg	Injectable suspension	L.L
R07AA	INFASURF	B	Calfactant - 210mg/6ml	35mg/ml	Injectable suspension	40,596,749 L.L
R07AA	INFASURF	B	Calfactant - 105mg/3ml	35mg/ml	Injectable suspension	23,344,161 L.L
H02AB01	DIPROFOS	B	Betamethasone (dipropionate) - 5mg/ml, Betamethasone (sodium phosphate) - 2mg/ml		Injectable suspension	446,156 L.L
H02AB04	DEPO MEDROL	B	Methylprednisolone acetate - 40mg/ml	40mg/ml	Injectable suspension	182,763 L.L
H02AB04	DEPO MEDROL	B	Methylprednisolone acetate - 80mg/2ml	80mg/2ml	Injectable suspension	365,525 L.L
L01BC07	AZACITIDINE ARROW	G	Azacitidine - 25mg/ml	25mg/ml	Injectable suspension	10,967,854 L.L
H02AB08	TRIACORT	G	Triamcinolone acetonide - 40mg/ml	40mg/ml	Injectable suspension	745,833 L.L
N02CD02	EMGALITY	BioTech	Galcanezumab - 120mg/ml	120mg/ml	Injectable suspension	37,250,732 L.L
J01DD04	LEBACEF	G	Ceftriaxone - 1g	1g	Injectable sterile powder for solution + lidocaine solvent	508,100 L.L
J01DD04	LEBACEF	G	Ceftriaxone - 1g	1g	Injectable sterile powder for solution + lidocaine solvent	508,100 L.L
A02BC01	ULCAZAL	G	Omeprazole (sodium) - 40mg	40mg	Injectable sterile lyophilised powder for solution	895,895 L.L
A02BC01	ULCAZAL	G	Omeprazole (sodium) - 40mg	40mg	Injectable sterile lyophilised powder for solution	5,916,747 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	840,861 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	5,875,791 L.L
J07BD52	M-M-R II (MEASLES, MUMPS AND RUBELLA VIRUS VACCINE LIVE)	B	Rubella virus live attenuated - , Mumps virus live attenuated - , Measles virus live attenuated -		Injectable solution+diluent	12,924,401 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 8mg	8mg	Injectable solution prolonged release	8,524,771 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 16mg	16mg	Injectable solution prolonged release	8,524,771 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 24mg	24mg	Injectable solution prolonged release	8,524,771 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 32mg	32mg	Injectable solution prolonged release	8,524,771 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 64mg	64mg	Injectable solution prolonged release	34,835,645 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 96mg	96mg	Injectable solution prolonged release	34,835,645 L.L

Diphteria Toxoid - ?20IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg